Latest from Emily Rauhala
U.S. could have 300 million extra vaccine doses by end of July, raising concerns about hoarding
The Biden administration is facing renewed pressure to facilitate equitable vaccine distribution around the world.
- Apr 15, 2021
Nearly 20 percent of the U.S. population is fully vaccinated. Many countries may not hit that target this year.
The widening gap is fueling frustration and potentially extending the pandemic.
- Apr 8, 2021
WHO report leaves unsettled ‘lab-leak’ theory on origins of covid pandemic
The director of the World Health Organization may have breathed new life into the theory, often dismissed as a political distraction, that the coronavirus came from a lab in China.
- Mar 30, 2021
WHO chief, U.S. and other world leaders criticize China for limiting access of team researching coronavirus origins
The comments came in response to a report on a joint WHO-Chinese team’s month-long visit to Wuhan.
- Mar 30, 2021
- Post Reports
Scamming pandemic relief
How scammers raked in millions of dollars in pandemic relief fraud schemes. Advice for vaccinated parents about what to do with their unvaccinated kids. And, what we know about the origin of the coronavirus.
- Mar 30, 2021
The best memes about the big, stuck ship
There is a big boat stuck in the Suez Canal. The world is very worried about the economic fallout. The Internet is very amused.
- Mar 29, 2021
WHO Wuhan report leaves question of coronavirus origins unresolved
The findings may be overshadowed by questions about China’s lack of transparency — and the WHO’s apparent inability to press for more.
- Mar 29, 2021
Five details from the WHO-led report on coronavirus origins
A “very likely” scenario was that the virus was passed to humans through an unknown animal, the report concludes.
- Mar 29, 2021
U.S., E.U., Canada and Britain announce sanctions on China over the abuse of Uyghurs
The coordinated move aims to hold Beijing accountable for the crackdown in the Xinjiang region.
- Mar 22, 2021
Drug companies defend vaccine monopolies in face of global outcry
Despite rising alarm over the immunization gap and widespread calls for greater cooperation, drug companies are hewing to the industry’s standard playbook when it comes to protecting valuable vaccine patents and manufacturing know-how.
- Mar 20, 2021